SARS-CoV-2 evades natural killer cell cytotoxic responses
Por um escritor misterioso
Descrição
In a recent study posted to the bioRxiv* preprint server, researchers at Stanford University School of Medicine revealed the mechanism via severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) escapes natural killer (NK) cell cytotoxic reactions.
Cytotoxic T cell - Wikipedia
SARS-CoV-2 and HIV-1: So Different yet so Alike. Immune Response at the Cellular and Molecular Level
Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?, Cell Communication and Signaling
The Development of Natural Killer Cells for Solid Tumor Treatment
Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2
Frontiers HLA-C dysregulation as a possible mechanism of immune evasion in SARS-CoV-2 and other RNA-virus infections
State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation
An outlook on potential protein targets of COVID-19 as a druggable site
Natural killer cell - Wikipedia
SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D
Natural killer cells in antiviral immunity
Frontiers Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies
Incursions by severe acute respiratory syndrome coronavirus-2 on the host anti-viral immunity during mild, moderate, and severe coronavirus disease 2019 disease
de
por adulto (o preço varia de acordo com o tamanho do grupo)